| |
| |
|
| Insider
Information: |
Main Alan J |
| Relationship: |
EVP, Innov & Chem Scie... |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
255,724 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$404,044 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
255,724 |
|
|
| Total
Value |
$404,044 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
EVP, Innov & Chem Scie... |
2024-02-28 |
255,724 |
2009-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Innov & Chem Sciences |
• • – |
2024-02-28 |
4 |
D |
$2.62 |
$63,949 |
D/D |
(24,408) |
255,724 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Innov & Chem Sciences |
• • – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
67,546 |
280,132 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Innov & Chem Sciences |
• • – |
2023-02-28 |
4 |
D |
$2.17 |
$45,453 |
D/D |
(20,946) |
212,586 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Innov & Chem Sciences |
• • – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,943 |
233,532 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Innov & Chem Sciences |
• • – |
2022-02-28 |
4 |
D |
$2.85 |
$56,305 |
D/D |
(19,756) |
175,589 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Innov & Chem Sciences |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
54,650 |
195,345 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Innov & Chem Sciences |
• • – |
2021-02-28 |
4 |
D |
$7.19 |
$146,769 |
D/D |
(20,413) |
140,695 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Innov & Chem Sciences |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
56,468 |
161,108 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Commercial Supply Ops |
• • – |
2020-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,893 |
111,453 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Commercial Supply Ops |
• • – |
2020-04-22 |
4 |
D |
$1.96 |
$13,353 |
D/D |
(6,813) |
104,640 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Commercial Supply Ops |
• • – |
2020-02-28 |
4 |
D |
$2.77 |
$35,342 |
D/D |
(12,759) |
91,560 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Commercial Supply Ops |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,252 |
104,319 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Commercial Supply Ops |
• • – |
2019-02-28 |
4 |
D |
$5.51 |
$37,936 |
D/D |
(6,885) |
67,067 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Commercial Supply Ops |
• • – |
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,151 |
73,952 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Commercial Supply Ops |
• • – |
2018-02-28 |
4 |
D |
$8.53 |
$42,326 |
D/D |
(4,962) |
53,801 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Commercial Supply Ops |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,533 |
58,763 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, CMC and Supply Operations |
• • – |
2017-02-28 |
4 |
D |
$16.45 |
$88,188 |
D/D |
(5,361) |
44,230 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, CMC and Supply Operations |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,391 |
49,591 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, CMC and Supply Operations |
• • – |
2016-02-29 |
4 |
D |
$9.07 |
$43,119 |
D/D |
(4,754) |
35,200 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, CMC and Supply Operations |
• • – |
2016-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,807 |
39,954 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, CMC and Supply Operations |
• • – |
2015-03-02 |
4 |
D |
$0.94 |
$23,799 |
D/D |
(25,318) |
190,032 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, CMC and Supply Operations |
• • – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
69,000 |
215,350 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Pharmaceutical Research |
• • – |
2014-02-28 |
4 |
D |
$1.92 |
$35,843 |
D/D |
(18,668) |
146,350 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Pharmaceutical Research |
• • – |
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,250 |
165,018 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Pharmaceutical Research |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,750 |
127,340 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
